OHSU Knight Cancer Institute

IRB #

STUDY00025328

Title

Investigating sex and gender-related differences in immunotherapy treatment effects

Principal Investigator

Deanne Tibbitts

Study Purpose

Some people with cancer experience side effects from immunotherapy. The purpose of the INSITE study is to identify how side effects of immunotherapy treatment change over time and whether side effects are different depending on your sex or gender.

Medical Condition(s)

cancer treated with immunotherapy

Eligibility Criteria

You may be eligible if you:

• Are at least 18 years old
• Have been diagnosed with cancer (any type except breast, prostate, testicular, or gynecologic cancer)
• Will soon begin immunotherapy

Age Range

18 - none

Healthy Volunteers Needed

No

Duration of Participation

Study participants will complete a brief symptom survey weekly for 6 months.

Minors Included

No

Contact

Please contact Dr. Deanne Tibbitts at tibbitts@ohsu.edu or call 503-494-4361.

Sponsor

National Institutes of Health (NIH)

Recruitment End

06/01/2024

Compensation Provided

Yes

Compensation

Study participants will receive up to $60 for completing surveys.